S22-302 Blood-based inflammatory biomarkers for the prediction of post-operative cognitive decline after surgery Stanford scientists develop a method for assessing patient risk of developing postsurgical neurocognitive complications using a combination of biomarkers. This method will ensure improved interventions and treatment outcomes. Brice Gaudilliere Julien Hedou Franck Verdonk